Open AccessAngiotensin II and COVID-19. Secrets of interactions
Author(s) -
Alexandra Konradi,
А. О. Недошивин
Publication year - 2020
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2020-3861
Subject(s) - medicine , covid-19 , renin–angiotensin system , angiotensin receptor blockers , peptidyl dipeptidase a , angiotensin converting enzyme 2 , angiotensin ii , angiotensin converting enzyme , pharmacology , virology , receptor , disease , blood pressure , outbreak , infectious disease (medical specialty)
The article describes current data on the relationship of renin-angiotensin system and related drugs with the risk of COVID-19 infection and its outcomes. Analysis of the latest publications did not reveal association of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with any risk of an unfavorable outcomes, and there was no data for withdrawal of these drugs.